The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2013Six-month Oral Toxicity Study of the Accordion Pill™ of Carbidopa/Levodopa
Objective/Rationale:
The Accordion Pill™ is designated to significantly stabilize the pharmacokinetic profile of drugs with a narrow absorption window, such as levodopa. Regular controlled-release... -
Target Validation, 2012Validating Monoacylglycerol Lipase Inhibitors in Combatting Parkinson’s Disease
Objective/Rationale:
Chronic and persistent inflammation in the brain has been shown to be an underlying driver of Parkinson’s disease (PD). Anti-inflammatory strategies may be beneficial... -
Dyskinesia Challenge, 2012Evaluation of Cortical Resonant Oscillations as a Novel Target for Treatment of Dyskinesia
Objective/Rationale:
In our research we aim to identify changes in neuronal circuits that cause motor symptoms in Parkinson’s disease (PD) by recording neuronal activity in healthy and in... -
Rapid Response Innovation Awards, 2013Transcranial Direct Current Stimulation for the Treatment of Parkinson’s Disease
Objective/Rationale:
Current treatments for Parkinson’s disease (PD) are either associated with side effects, expensive, or their efficacy diminishes over time. Thus, the development of practical... -
MJFF Research Grant, 2013A New Tool for CSF-Based Parkinson Disease Diagnostics: Super-Resolution Microscopy Investigation of Alpha-Synuclein Aggregates
Objective/Rationale:
It is still difficult to diagnose Parkinson’s Disease (PD) patients through routine assays. Clinical research on PD suggests that the aggregation (clumping) of the... -
Target Validation, 2013Validation of the Transcriptional Repressor Bach1 as a Novel Target to Enhance Antioxidant Response Pathway and Block Neurodegeneration in Parkinson’s Disease
Objective/Rationale:
Bach1 is a transcriptional repressor, which is a protein that binds to a specific DNA site and prevents transcription of nearby genes. Bach1 is primarily localized to...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.